Previous Close | 13.46 |
Open | 13.47 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 12.94 - 13.47 |
52 Week Range | 5.76 - 16.94 |
Volume | |
Avg. Volume | 158,698 |
Market Cap | 543.309M |
Beta (5Y Monthly) | 2.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Third Harmonic Bio...
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
Natalie Holles, Chief Executive Officer of Third Harmonic Bio Inc (NASDAQ:THRD), sold 20,222 shares of the company on May 9, 2024.